1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Overweight Subjects: new trials by email Literature Review of Overweight Subjects trials Research Report on Overweight Subjects
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Drug-drug Interactions (DDIs) of IBI362 With Metformin, Warfarin, Atorvastatin, Digoxin in Overweight or Obese Subjects metformin, digoxin, IBI362 - Overweight Subjects, Obese Subjects | Phase 1 | Completed | Innovent Biologics (Suzhou) Co. Ltd. | 48 | 2023-04-06 | 2023-11-14 |
Atorvastatin (1) · Digoxin (1) · Metformin (1) · Warfarin (1) · mazdutide (1)
Innovent Biologics (Suzhou) Co. Ltd. (1)
China (1)